CRSP — CRISPR THERAPEUTICS AG

Ownership history in GSK plc  ·  1 quarter on record

This page tracks every 13F SEC filing in which GSK plc reported a position in CRISPR THERAPEUTICS AG (CRSP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
21.14% (2025 Q4)
Avg. % of fund
21.14%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 3,220,627 — — 21.14% $168.9M $52.44
% of Fund (quarterly)    CRSP price (monthly, adj. close)

Other funds also holding CRSP

As of 2025 Q4 — sorted by position size

SR ONE CAPITAL MANAGEMENT, LP 3Y 15.14% Versant Venture Management, LLC 3Y 7Y 5.17% ARK Investment Management LLC 3Y 7Y 3.66% EcoR1 Capital, LLC 3Y 7Y 3.31% NEA Management Company, LLC 3Y 7Y 2.83% Green Alpha Advisors, LLC 3Y 2.68% Stonepine Capital Management, LLC 3Y 7Y 1.91% IQ EQ FUND MANAGEMENT (IRELAND) Ltd 3Y 7Y 1.41% Orbis Allan Gray Ltd 3Y 7Y 1.31% Amova Asset Management Americas, Inc. 3Y 7Y 1.19%
← Back to GSK plc Holdings